New Frontier Corporation
Status: Deal Closed
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $287.50M |
|---|---|
| IPO Date | Jun 28, 2018 |
| CEO | Carl Wu |
| Left Lead | Credit Suisse |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
General
Healthcare, technology or education sectors in China |
| IPO Geography | Asia |
| Target Company | United Family Healthcare |
| Deal Announced | Jul 30, 2019 |
| Deal Size, $M | $1,440.00M |
| Deal Sector | Healthcare |
| Deal Geography | Asia |
| SEC Filings | www.sec.gov |
| Approval Vote | Dec 12, 2019 |
| Amendment Vote | TBD |
| Closing Date | Dec 19, 2019 |
Formerly NFC
NFH
NFH/W
| Price | 11.95 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on New Frontier Corporation:
- Structure and cap table
- 7 directors & officers
- 26 filings and events
- 3 underwriters
- 2 deal advisors
- 8 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Antony Leung | 66 | Chairman |
| Carl Wu | 34 | Chief Executive Officer, Director |
| Edward Leong Che-hung | 79 | Director |
| Frederick Ma Si-hang | 66 | Director |
| David L. Johnson | 64 | Director |
| Harry Chang | 44 | Vice President of Corporate Development, Secretary |
| Shuo Wang | 30 | Chief Financial Officer |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Credit Suisse | Joint BR | 14,650,000 | units |
| UBS | Joint BR | 9,750,000 | |
| I-Bankers Securities | 600,000 | ||
| 25,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.